Office of Research Distinguished Speaker Series in Research and Innovation – COVID-19 Vaccines: Efficacy and Perspectives on Progress - Office of Research

Distinguished Speaker Series in Research and Innovation – COVID-19 Vaccines: Efficacy and Perspectives on Progress

Distinguished Speaker Series in Research and Innovation – COVID-19 Vaccines: Current and Future Efficacy and Perspectives on Progress

March 31, 2021
Join us for a unique opportunity to hear from Dr. Lawrence Corey, an internationally renowned expert in virology, immunology and vaccine development. Dr. Corey will provide insight on the current and future efficacy of COVID-19 vaccines and his perspectives on progress.

This event is cohosted by the UC Davis School of Medicine and Office of Research.

Event Details

April 16, 2021
10:30 to 11:30 am

Registration is required

Register

Who Should Attend?

UC Davis faculty, clinicians, staff, students and their research partners. Media representatives are also welcome to attend.

About the Speaker

Lawrence Corey, MD
Past President and Director, Fred Hutchinson Cancer Research Center
Professor, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Professor, Medicine and Laboratory Medicine, University of Washington

Dr. Larry Corey is an internationally renowned expert in virology, immunology and vaccine development, and the former president and director of the Fred Hutchinson Cancer Research Center. His research focuses on herpes viruses, HIV, the novel coronavirus and other viral infections, including those associated with cancer. He is principal investigator of the HIV Vaccine Trials Network, or HVTN, which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership, the HVTN has become the model for global, collaborative research. Dr. Corey is also the principal investigator of the Fred Hutch-based operations center of the COVID-19 Prevention Network (CoVPN) and co-leads the Network’s COVID-19 vaccine testing pipeline. The CoVPN is carrying out the large Operation Warp Speed portfolio of COVID-19 vaccines and monoclonal antibodies intended to protect people from COVID-19.

Dr. Corey is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences, and was the recipient of the Parran Award for his work in HSV-2, the American Society of Microbiology Cubist Award for his work on antivirals, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author, coauthor or editor of over 1000 scientific publications.

Share This Story


More Stories